Tumor markers such as CA19-9, carcinoembryonic antigen (CEA), sialyl-Lewis X (SLX), and lactate dehydrogenase (LDH) showed a difference in their concentrations in patients with ovarian cancer vs. patients with endometriosis [275]. Here, CEACAM5 is linked to neoplasm.